The Trump administration proposes a rule by the Centers for Medicare & Medicaid Services to limit hospital markups on drugs bought under the 340B program, aiming to cut Medicare reimbursements by about 40 percent and save Medicare Part B patients roughly $800 annually and $1.1B next year.The rule would cap payments at the average sales price minus 33.4 percent; Centers for Medicare & Medicaid Services cites Lupron Depot as an example, saying hospitals can acquire it for about $700 while Medicare reimbursements can reach roughly $4,000 plus $1,000 in co-payments.The proposal follows an executive order earlier this year, echoes a similar attempt during President
Donald Trump’s first term that the Supreme Court struck down in 2022, and faces likely legal and political challenges from hospital systems worried about revenue and community services.